AAAAAA

   
Results: 1-8 |
Results: 8
Effect of therapeutic immunization with HIV type 1 recombinant glycoprotein 160 ImmunoAG vaccine in HIV-infected individuals with CD4(+) T cell counts of <= 500 and 200-400/mm(3) (AIDS Clinical Trials Group study 246/946)
Authors: Kundu-Raychaudhuri, S Sevin, A Kilgo, P Nokta, M Pollard, RB Merigan, TC
Citation: S. Kundu-raychaudhuri et al., Effect of therapeutic immunization with HIV type 1 recombinant glycoprotein 160 ImmunoAG vaccine in HIV-infected individuals with CD4(+) T cell counts of <= 500 and 200-400/mm(3) (AIDS Clinical Trials Group study 246/946), AIDS RES H, 17(15), 2001, pp. 1371-1378
Shipment impairs lymphocyte proliferative responses to microbial antigens
Authors: Betensky, RA Connick, E Devers, J Landay, AL Nokta, M Plaeger, S Rosenblatt, H Schmitz, JL Valentine, F Wara, D Weinberg, A Lederman, HM
Citation: Ra. Betensky et al., Shipment impairs lymphocyte proliferative responses to microbial antigens, CL DIAG LAB, 7(5), 2000, pp. 759-763
Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activation
Authors: Fahey, JL Aziz, N Spritzler, J Plaeger, S Nishanian, P Lathey, JL Seigel, J Landay, AL Kilarui, R Schmitz, JL White, C Wara, DW Akridge, R Cutili, J Douglas, SD Reuben, J Shearer, WT Nokta, M Polland, R Schooley, R Asthana, D Mizrachi, Y Waxdal, M
Citation: Jl. Fahey et al., Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activation, CL DIAG LAB, 7(4), 2000, pp. 540-548
Neutralization profiles of sera from human immunodeficiency virus (HIV)-infected individuals: Relationship to HIV viral load and CD4 cell count
Authors: Nokta, M Turk, P Loesch, K Pollard, RB
Citation: M. Nokta et al., Neutralization profiles of sera from human immunodeficiency virus (HIV)-infected individuals: Relationship to HIV viral load and CD4 cell count, CL DIAG LAB, 7(3), 2000, pp. 412-416
Co-receptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient?
Authors: Lathey, JL Brambilla, D Goodenow, MM Nokta, M Rasheed, S Siwak, EB Bremer, JW Huang, DD Yi, YJ Reichelderfer, PS Collman, RG
Citation: Jl. Lathey et al., Co-receptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient?, J LEUK BIOL, 68(3), 2000, pp. 324-330
Absence of virological changes after acute febrile illnesses in two patients with undetectable pre-illness plasma HIV-1-RNA levels
Authors: Sha, BE Johnson, VA Kendall, MA Haubrich, R Nokta, M Lamb, K Zackin, RA Nail, CD Currier, JS
Citation: Be. Sha et al., Absence of virological changes after acute febrile illnesses in two patients with undetectable pre-illness plasma HIV-1-RNA levels, AIDS, 14(6), 2000, pp. 746-748
A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates
Authors: Landry, ML Stanat, S Biron, K Brambilla, D Britt, W Jokela, J Chou, SW Drew, WL Erice, A Gilliam, B Lurain, N Manischewitz, J Miner, R Nokta, M Reichelderfer, P Spector, S Weinberg, A Yen-Lieberman, B Crumpacker, C
Citation: Ml. Landry et al., A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates, ANTIM AG CH, 44(3), 2000, pp. 688-692
Effect of didanosine, stavudine, and hydroxyurea therapy on apoptosis in CD45RA(+) and CD45RO(+) T lymphocyte subpopulations
Authors: Nokta, M Rossero, R Nichols, J Rosenbaum, M Pollard, RB
Citation: M. Nokta et al., Effect of didanosine, stavudine, and hydroxyurea therapy on apoptosis in CD45RA(+) and CD45RO(+) T lymphocyte subpopulations, AIDS RES H, 15(3), 1999, pp. 255-264
Risultati: 1-8 |